Wanda Appoints Medical Director

RNS Number : 3124F
NetScientific PLC
27 July 2016
 

 

 

("NetScientific" or the "Company" or the "Group")

 

Wanda Names Dr. Suzanne Steinbaum, Renowned Cardiologist and Women's Heart Health Advocate, as Medical Director

 

Dr. Steinbaum joins Wanda's mission to create personalized health guidance and accountability using advanced predictive analytics, behavioural science, and mobile technologies.

 

London, UK - 27 July 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic biomedical and healthcare technology  group, notes Wanda's announcement of the appointment of Dr. Suzanne Steinbaum, a board-certified cardiologist and well-known national advocate for women's heart health, as Medical Director.

 

Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific, said: "Dr. Steinbaum's extensive clinical experience and background in cardiology will make her a valuable addition to Wanda's already distinguished team."

 

The full text of the announcement issued by Wanda on 26 July 2016 is as follows:

 

 

 

Dr. Suzanne Steinbaum, Renowned Cardiologist and Women's Heart Health Advocate, Named Medical Director for Wanda

 

Dr. Steinbaum joins Wanda's mission to create personalized health guidance and accountability using advanced predictive analytics, behavioral science, and mobile technologies.

 

SAN FRANCISCO - July 26, 2016 - Wanda, a leading digital health platform dedicated to advancing the effectiveness and efficiency of patient care, today announced that Dr. Suzanne Steinbaum, board-certified cardiologist and well-known national advocate for women's heart health, has joined the company as Medical Director.

 

Dr. Steinbaum is a Fellow of the American College of Cardiology and a Fellow of the American Heart Association, and has been trained in both Cardiology and Preventative Cardiology. She is also a National Spokesperson for the American Heart Association's Go Red for Women campaign and chairs Go Red for Women in New York City. She will lend her world-class expertise and leadership to further Wanda's mission of empowering users to improve their own health through data-driven insights and personalized guidance.

 

"We're thrilled to have Dr. Steinbaum join our distinguished team of data scientists, engineers, and designers to help us focus on tackling mankind's number one killer: heart disease," said Wanda's CEO Steve Curd"Dr. Steinbaum adds an invaluable amount of clinical competence and a deep understanding of what it takes to keep people at risk of heart disease out of the hospital."

 

Wanda's digital health platform collects critical information from individuals and utilizes machine learning to deliver ongoing risk analysis and decision support. Combined with a smart, inspirational, and engaging interface, Wanda's capabilities enable users to better manage their own cardiovascular health. The result is not only a higher quality of life, but a significant reduction in the cost burden of these individuals.

 

"Wanda is at the forefront of a critical turning point in healthcare, in which patient engagement is essential to successful outcomes," said Dr. Steinbaum. "I have devoted my entire career to the treatment of heart disease through early detection, education, and prevention. The moment I met the Wanda team, I realized our collaboration could provide an incredibly unique force in preventing our country's number one killer. While heart disease is 80 to 90% preventable, lifestyle changes are critical, and this is where Wanda comes in. Wanda's ability to monitor health markers and personalize recommendations to create impactful changes for the individual will ultimately change outcomes."

 

Despite the fact that over 50% of heart-related hospitalizations are avoidable, heart disease remains one of America's most expensive health challenges. Until now, no one has brought together all of the pieces necessary to impact this immense problem at scale, which drives an estimated $100 billion of cost in the US alone.

 

"Instead of treating people as 'passive data sources' to be tested, examined, treated, and often criticized for non-compliance, we believe that the only effective approach is to engage each individual in a meaningful dialog to personalize the experience," says Mark Heinemeyer, CCO for Wanda. "As we learn more about each individual, we can guide them to make more intelligent, accountable decisions affecting their hearts."

 

 

 

- Ends -

 

 

For more information, please contact:

 

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

 

Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

 

 

About NetScientific Plc

 

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.  For more information, please visit the website at www.netscientific.net.

 

About Wanda

San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.

 

About Dr. Suzanne Steinbaum

Dr. Suzanne Steinbaum is an attending cardiologist and the Director of Women's Heart Health of Lenox Hill Hospital in New York City. She has done fellowship training in both Preventive Cardiology and Cardiology. She recently released her book Dr. Suzanne Steinbaum's Heart Book: Every Woman's Guide to a Heart Healthy Life, teaching all women how to lead the healthiest lives by living from the heart. She is the host of Focus onHealth, a weekly magazine news show spotlighting health topics, seen on WLNYTV. She has been awarded a New York Times Super Doctor, and a Castle and Connolly Top Doctor for Cardiovascular Disease.

 

Dr. Steinbaum is a Fellow of the American College of Cardiology and a Fellow of the American Heart Asssociation in Epidemiology and Prevention. She is a National Spokesperson for the Go Red for Women campaign and chairperson of Go Red for Women in New York City.

 

Dr. Steinbaum has devoted her career to the treatment of heart disease through early detection, education, and prevention. She has lectured nationally on topics of coronary artery disease, women and heart disease, natural and alternative ways of treating heart disease and the prevention of heart disease. She is often cited in magazines and newspapers and is regularly seen on network news health segments for ABC, NBC and CBS, CNN, WPIX and FOX as a leading consultant in the field of women and heart disease, preventive cardiology and topics of lifestyle management. She is regularly interviewed for breaking news in U.S. News and World Report, Healthday and WebMD. She has written on topics of cardiac prevention and nutrition and has been quoted in many publications and magazines, such as Self, Glamour, More, Fitness, The Wall Street Journal and Family Circle. She is a regular contributor to The Huffington Post, Dr. Oz, Bottomline Health, and Sharecare.

 

Her unique perspectives on health, wellness and overall vitality by living a heart-centered life can be found at www.srsheart.com, on Facebook at Dr. Suzanne Steinbaum and Twitter at @DrSteinbaum.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUMUMUPQGQQ

Companies

Emv Capital (EMVC)
UK 100

Latest directors dealings